Hepatic steatosis: A specific sign of hepatitis C reinfection after liver transplantation

Liver Transplantation and Surgery

Volumn 4, Issue 6, 1998, Pages 441-447

  Baiocchi, L ^a   Tisone, G ^a   Palmieri, G ^a   Rapicetta, M ^a   Pisani, F ^a   Orlando, G ^a   Casciani, C U ^a   Angelico, M ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FATTY LIVER; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION;

EID: 0031789609     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040613     Document Type: Article

References (19)

1. 1 Alter MJ. Epidemiology of hepatitis in the West. Semin Liver Dis 1995 ; 15: 5–14. MEDLINE
2. 2 Di Bisceglie A, Goodman Z, Ishak K, Hoofnagle J, Melpolder J, Alter H. Long‐term clinical and histopathological follow‐up of post‐transfusion hepatitis. Hepatology 1991 ; 14: 969–974. MEDLINE
3. 3 Konig V, Bauditz J, Lobeck H, Lusebrink R, Neuhaus P, Blumhardt G, et al. Hepatitis C virus reinfection in allografts after ortothopic liver transplantation. Hepatology 1992 ; 16: 1137–1143. MEDLINE
4. 4 Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C virus reinfection in liver transplant recipients. Gastroenterology 1992 ; 103: 317–322. MEDLINE
5. 5 Rapicetta M, Attili AF, Mele A, De Santis A, Chionne P, Cristiano K, et al. Prevalence of hepatitis C virus antibodies and hepatitis C virus‐RNA in an urban population. J Med Virol 1992 ; 37: 87–92. MEDLINE
6. 6 Gretch DR, Bacchi CE, Corey L, Della Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features. Hepatology 1995 ; 22: 1–9. MEDLINE
7. 7 Gane EJ, Portmannet BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long‐term outcome of hepatitis C infection after liver transplantation. New Engl J Med 1996 ; 13: 815–820.
8. 8 Belli SL, Silini E, Alberti A, Bellati G, Vai C, Minola E, et al. Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transplant Surg 1996 ; 3: 200–205.
9. 9 Schluger LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996 ; 5: 971–976.
10. 10 Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992 ; 15: 567–571. MEDLINE
11. 11 Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC, et al. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. Gastroenterology 1993 ; 104: 595–603. MEDLINE
12. 12 Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuu Y, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 1997 ; 94: 1200–1205. MEDLINE
13. 13 Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997 ; 78: 1527–1531. MEDLINE
14. 14 Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995 ; 76: 3031–3038. MEDLINE
15. 15 Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after transplantation. Gastroenterology 1995 ; 108: 1088–1096. MEDLINE
16. 16 Araya V, Rakela J, Wright T. Hepatitis C after orthotopic liver transplantation. Gastroenterology 1997 ; 112: 575–582. MEDLINE
17. 17 Wright TL, Combs C, Kim M, Ferrell L. Interferon‐alfa therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994 ; 20: 773–779. MEDLINE
18. 18 Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 1995 ; 22: 1084–1089. MEDLINE
19. 19 Gadano AC, Mosnier JF, Durand F, Martinot Peignoux M, Marcellin P, Degott C, et al. Alfa‐interferon–induced rejection of a hepatitis C virus infected liver allograft tolerated with a low‐dosage immunosuppressive regimen. Transplantation 1995 ; 59: 1627–1629. MEDLINE